Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xiongjun Hou"'
Autor:
Hong Liu, Jiansheng Xiao, Hongwei Peng, Xiongjun Hou, Wei Xiaohua, Guozhen Liu Mr, Jing Yan, Ying Kong, Fu Qun, Lei Cao, Xuehui Jiang Mr, Pin Xiao, Pei Deng
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:600-608
WHAT IS KNOWN AND OBJECTIVES Tacrolimus (TAC), a first-line immunosuppressant in solid-organ transplant, has a narrow therapeutic window and large inter-individual variability, which affects its use in clinical practice. Successful predictions using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c4e3341c15521cdf159f5a1de560f5
https://doi.org/10.1111/jcpt.13579
https://doi.org/10.1111/jcpt.13579
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:1117-1128
What is known and objectives Tacrolimus (TAC) is a first-line immunosuppressant which is used to prevent transplant rejection after solid organ transplantation (SOT). However, it has a narrow therapeutic index and high individual variability in pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8202eccb5a140169e45df86e1c35ba
https://doi.org/10.1111/jcpt.13407
https://doi.org/10.1111/jcpt.13407
Publikováno v:
Molecular Medicine Reports; Aug2017, Vol. 16 Issue 2, p1383-1388, 6p